TREND Community’s Report on Sodium Oxybate Therapy in People With Narcolepsy

Matthew Horsnell
Matthew Horsnell
TREND Community Director

PHILADELPHIA, February 16, 2023 – TREND Community, a digital health analytics company with the bold vision to revolutionize the world’s understanding of diseases, today announced that its poster, titled “Understanding the Patient Experience With Sodium Oxybate Therapy for Narcolepsy,” will be presented at the Advances in Sleep and Circadian Science (ASCS) to be held February 17-20, 2023, in Clearwater Beach, Florida.

This poster is based on an abstract of the same title and provides evidence from both social media and survey results showing that the need to take a second dose of sodium oxybate is associated with various sleep-related issues and disruptions for people with narcolepsy and their caregivers. Daily functioning, physical and mental health, injuries, and quality of life were affected.

For the complete abstract, please visit the Sleep Research Society ASCS Abstract List:

The authors are Matthew Horsnell, Enming Zhang, Rachelle Cook, Lauren Dougherty, Allison Foley Shenk, Frederik Ascencion, Anne Marie Morse, Luis Ortiz, Wei Li, E. Robert Wassman, Christopher DeFelice, and Maria Picone

This work was funded by Avadel Pharmaceuticals to better understand the experience of people with narcolepsy and the need for a once-at-bedtime sodium oxybate therapy.

For additional information about this poster, please contact:
Matthew Horsnell,

For information about collaboration and partnerships with TREND, please contact:
Maria Picone,

About TREND Community

TREND Community turns the conversations of people who have rare, chronic, and emerging diseases and their caregivers/care partners into actionable insights through our proprietary evidence-accelerator approach. Above all, we prioritize the privacy and trust of every community member.

About Avadel

Avadel Pharmaceuticals is a biopharmaceutical company focused on transforming medicines to transform lives. Their approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options.